EDAP TMS SA (FOCL)

Currency in USD
4.230
-0.130(-2.98%)
Real-time Data·
Unusual trading volume
Earnings results expected in 0 days
FOCL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.0904.496
52 wk Range
1.3006.400
Key Statistics
Prev. Close
4.36
Open
4.39
Day's Range
4.09-4.496
52 wk Range
1.3-6.4
Volume
300.65K
Average Volume (3m)
84.47K
1-Year Change
185.4237%
Book Value / Share
-0.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FOCL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.600
Upside
+103.31%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

EDAP TMS SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 8.600
(+103.31% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Hold4.00-5.10%3.00MaintainAug 14, 2026
Lucid Capital Markets
Buy10.00+137.25%-New CoverageJun 22, 2026
H.C. Wainwright
Buy10.00+137.25%14.00MaintainApr 10, 2026
Piper Sandler
Hold2.50-40.69%1.50MaintainJan 20, 2026
Jefferies
Hold2.00-52.55%1.80MaintainNov 06, 2025

EDAP TMS SA Earnings Call Summary for Q2/2026

  • FocalTherics Q2 2026 HIFU revenue rose 39% YoY to $13.2M; capital system sales jumped 44% to 13 units, both quarterly records.
  • Gross margin expanded 450 bps to 55.6% from 51.1%, driven by lower costs and pricing discipline; company remains unprofitable operationally.
  • Company reiterated FY 2026 core HIFU revenue guidance of $50M-$54M; expects R&D and SG&A to decline as percentage of revenue over time.
  • Announced $40M equity offering closing Aug. 14 to fund commercial growth, expanded indications, and histotripsy development amid negative equity.
  • Stock fell 3.8% to $4.57 after-hours despite strong results; investors focused on losses and financing needs over revenue growth and margin gains.
Last Updated: 13/08/2026, 22:36
Read Full Transcript

Earnings

Latest Release
May 07, 2026
EPS / Forecast
-0.21 / -0.19
Revenue / Forecast
15.42M / 14.77M
EPS Revisions
Last 90 days

FOCL Income Statement

Compare FOCL to Peers and Sector

Metrics to compare
FOCL
Peers
Sector
Relationship
P/E Ratio
−4.9x−2.5x−0.3x
PEG Ratio
0.06−0.240.00
Price/Book
−59.8x2.2x2.6x
Price / LTM Sales
2.4x2.3x3.1x
Upside (Analyst Target)
129.4%14.1%49.0%
Fair Value Upside
Unlock−4.7%6.3%Unlock

EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. It also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. In addition, the company manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters; and sells spare parts and disposables, such as electrodes. Further, it markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
581.81K1.55%2.54M
Other Institutional Investors
14.56M38.84%63.47M
Public Companies & Retail Investors
22.34M59.61%97.42M
Total
37.48M100.00%163.42M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Soleus Capital Management, L.P.19.50%7,309,25431,868
Morgan Stanley8.93%3,345,28014,585

People Also Watch

123.68
FORM
-10.48%
8.0150
ASTC
-1.78%
4.910
BWEN
-6.83%
145.24
CHRW
+0.32%
171.79
CINF
+0.43%

FAQ

What Is the EDAP (FOCL) Stock Price Today?

The EDAP stock price today is 4.230 USD.

What Stock Exchange Does EDAP Trade On?

EDAP is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for EDAP?

The stock symbol for EDAP is "FOCL."

What Is the EDAP (FOCL) Afterhours Price Today? (Afterhours variable test: 4.450) Current Date: Aug 18, 2026

After hours price: 4.450. After hours price change (units): 0.090. Price change percentage: 2.060%

What Is the EDAP Market Cap?

As of today, EDAP market cap is 200.150M USD.

What Is EDAP's Earnings Per Share (TTM)?

The EDAP EPS (TTM) is -1.044.

When Is the Next EDAP Earnings Date?

EDAP will release its next earnings report on Aug 26, 2026.

From a Technical Analysis Perspective, Is FOCL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has EDAP Stock Split?

EDAP has split 0 times.

How Many Employees Does EDAP Have?

EDAP has 289 employees.

What is the current trading status of EDAP (FOCL)?

As of Aug 18, 2026, EDAP (FOCL) is trading at a price of 4.230 USD, with a previous close of 4.360 USD. The stock has fluctuated within a day range of 4.090 USD to 4.496 USD, while its 52-week range spans from 1.300 USD to 6.400 USD.

What Is EDAP (FOCL) Price Target According to Analysts?

The average 12-month price target for EDAP is 8.600 USD, with a high estimate of 15 USD and a low estimate of 3 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +103.31% Upside potential.

What Is the FOCL Premarket Price?

FOCL's last pre-market stock price is 4.400 USD. The pre-market share volume is 8.000, and the stock has decreased by 0.040, or 0.920%.

What Is the FOCL After Hours Price?

FOCL's last after hours stock price is 4.450 USD, the stock has decreased by 0.090, or 2.060%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.